

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of pigment cell differentiation (GO:0050932) | 8.12074849 |
| 2 | positive regulation of developmental pigmentation (GO:0048087) | 7.84487353 |
| 3 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 7.56812011 |
| 4 | regulation of meiosis I (GO:0060631) | 7.55979970 |
| 5 | DNA methylation involved in gamete generation (GO:0043046) | 7.46310046 |
| 6 | protein-chromophore linkage (GO:0018298) | 7.34286089 |
| 7 | lipopolysaccharide biosynthetic process (GO:0009103) | 6.82517985 |
| 8 | lipopolysaccharide metabolic process (GO:0008653) | 6.14042182 |
| 9 | sulfate transmembrane transport (GO:1902358) | 6.02055282 |
| 10 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 5.59848276 |
| 11 | regulation of protein glycosylation (GO:0060049) | 5.56184731 |
| 12 | piRNA metabolic process (GO:0034587) | 5.39907340 |
| 13 | paraxial mesoderm development (GO:0048339) | 5.20402788 |
| 14 | sulfate transport (GO:0008272) | 5.18967869 |
| 15 | meiotic chromosome segregation (GO:0045132) | 5.11627852 |
| 16 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 5.01798871 |
| 17 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 4.96391934 |
| 18 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 4.92788030 |
| 19 | heme transport (GO:0015886) | 4.89466237 |
| 20 | germinal center formation (GO:0002467) | 4.75409219 |
| 21 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 4.58653500 |
| 22 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.53510090 |
| 23 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 4.40641201 |
| 24 | vitamin transmembrane transport (GO:0035461) | 4.37152477 |
| 25 | sympathetic nervous system development (GO:0048485) | 4.34430981 |
| 26 | positive regulation of meiosis (GO:0045836) | 4.24104572 |
| 27 | rhodopsin mediated signaling pathway (GO:0016056) | 4.17284397 |
| 28 | tyrosine metabolic process (GO:0006570) | 4.16348887 |
| 29 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.09407785 |
| 30 | L-phenylalanine catabolic process (GO:0006559) | 4.09407785 |
| 31 | response to nitrosative stress (GO:0051409) | 4.02453264 |
| 32 | ribonucleoprotein complex disassembly (GO:0032988) | 3.99346585 |
| 33 | regulation of developmental pigmentation (GO:0048070) | 3.95383883 |
| 34 | positive regulation of meiotic cell cycle (GO:0051446) | 3.92665873 |
| 35 | flavonoid metabolic process (GO:0009812) | 3.90072597 |
| 36 | notochord development (GO:0030903) | 3.88676996 |
| 37 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.71795253 |
| 38 | DNA deamination (GO:0045006) | 3.67828292 |
| 39 | cellular response to reactive nitrogen species (GO:1902170) | 3.65509987 |
| 40 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.64981876 |
| 41 | SMAD protein complex assembly (GO:0007183) | 3.64855981 |
| 42 | serotonin receptor signaling pathway (GO:0007210) | 3.56894422 |
| 43 | reciprocal meiotic recombination (GO:0007131) | 3.55660176 |
| 44 | reciprocal DNA recombination (GO:0035825) | 3.55660176 |
| 45 | iron coordination entity transport (GO:1901678) | 3.55485600 |
| 46 | negative regulation of glycoprotein metabolic process (GO:1903019) | 3.54454099 |
| 47 | tachykinin receptor signaling pathway (GO:0007217) | 3.50460042 |
| 48 | centriole replication (GO:0007099) | 3.47323085 |
| 49 | regulation of odontogenesis (GO:0042481) | 3.37735571 |
| 50 | negative regulation of stem cell proliferation (GO:2000647) | 3.31191207 |
| 51 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.30426970 |
| 52 | L-phenylalanine metabolic process (GO:0006558) | 3.30426970 |
| 53 | cellular response to gamma radiation (GO:0071480) | 3.30111090 |
| 54 | heart valve formation (GO:0003188) | 3.28270607 |
| 55 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.26526992 |
| 56 | glutamate receptor signaling pathway (GO:0007215) | 3.25941128 |
| 57 | pantothenate metabolic process (GO:0015939) | 3.23446440 |
| 58 | protein kinase C-activating G-protein coupled receptor signaling pathway (GO:0007205) | 3.23099410 |
| 59 | postsynaptic membrane organization (GO:0001941) | 3.18406627 |
| 60 | sulfur compound transport (GO:0072348) | 3.11461388 |
| 61 | organelle disassembly (GO:1903008) | 3.09291991 |
| 62 | glycerol metabolic process (GO:0006071) | 3.08153870 |
| 63 | regulation of keratinocyte proliferation (GO:0010837) | 3.06992954 |
| 64 | regulation of interleukin-5 production (GO:0032674) | 3.06519897 |
| 65 | lysine metabolic process (GO:0006553) | 3.00099162 |
| 66 | lysine catabolic process (GO:0006554) | 3.00099162 |
| 67 | nodal signaling pathway (GO:0038092) | 2.99757120 |
| 68 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.99219430 |
| 69 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.98010834 |
| 70 | negative regulation of cell-matrix adhesion (GO:0001953) | 2.90350075 |
| 71 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.88655128 |
| 72 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.85926449 |
| 73 | activation of protein kinase A activity (GO:0034199) | 2.85818184 |
| 74 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.83495405 |
| 75 | L-fucose catabolic process (GO:0042355) | 2.82083064 |
| 76 | fucose catabolic process (GO:0019317) | 2.82083064 |
| 77 | L-fucose metabolic process (GO:0042354) | 2.82083064 |
| 78 | aromatic amino acid family catabolic process (GO:0009074) | 2.80822863 |
| 79 | synaptic transmission, glutamatergic (GO:0035249) | 2.80733868 |
| 80 | cell migration in hindbrain (GO:0021535) | 2.78412870 |
| 81 | response to mercury ion (GO:0046689) | 2.78224171 |
| 82 | negative regulation of mast cell activation (GO:0033004) | 2.77192707 |
| 83 | cellular response to nitric oxide (GO:0071732) | 2.75547297 |
| 84 | negative regulation of norepinephrine secretion (GO:0010700) | 2.72173792 |
| 85 | aspartate family amino acid catabolic process (GO:0009068) | 2.71104858 |
| 86 | regulation of uterine smooth muscle contraction (GO:0070472) | 2.69225739 |
| 87 | somite rostral/caudal axis specification (GO:0032525) | 2.68154189 |
| 88 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.67780851 |
| 89 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 2.64233865 |
| 90 | alditol metabolic process (GO:0019400) | 2.62760507 |
| 91 | positive regulation of amine transport (GO:0051954) | 2.61704894 |
| 92 | chemosensory behavior (GO:0007635) | 2.61587569 |
| 93 | adaptation of signaling pathway (GO:0023058) | 2.61435146 |
| 94 | cellular response to sterol (GO:0036315) | 2.59789189 |
| 95 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.59341087 |
| 96 | negative regulation of neural precursor cell proliferation (GO:2000178) | 2.58841432 |
| 97 | response to epinephrine (GO:0071871) | 2.56659337 |
| 98 | sphingosine metabolic process (GO:0006670) | 13.0002110 |
| 99 | diol metabolic process (GO:0034311) | 11.8510367 |
| 100 | sphingoid metabolic process (GO:0046519) | 11.2916814 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IGF1R_20145208_ChIP-Seq_DFB_Human | 4.88999588 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.35626480 |
| 3 | AR_21572438_ChIP-Seq_LNCaP_Human | 3.97513742 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.24498395 |
| 5 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 3.09597713 |
| 6 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.65920170 |
| 7 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.36482860 |
| 8 | P300_19829295_ChIP-Seq_ESCs_Human | 2.32842075 |
| 9 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.27104648 |
| 10 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.26432630 |
| 11 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.19269813 |
| 12 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.08354236 |
| 13 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.02966749 |
| 14 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.97769071 |
| 15 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.94304310 |
| 16 | FUS_26573619_Chip-Seq_HEK293_Human | 1.91308048 |
| 17 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.87083728 |
| 18 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.86338916 |
| 19 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.86338916 |
| 20 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.85626564 |
| 21 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.84743295 |
| 22 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.81634163 |
| 23 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.74073837 |
| 24 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.71197813 |
| 25 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.71190507 |
| 26 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.65092886 |
| 27 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.63267485 |
| 28 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.59177608 |
| 29 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.55082350 |
| 30 | TCF4_23295773_ChIP-Seq_U87_Human | 1.54101688 |
| 31 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.51699317 |
| 32 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.50937108 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.49646434 |
| 34 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.48206805 |
| 35 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.48206805 |
| 36 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.46693367 |
| 37 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.45705564 |
| 38 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.45458438 |
| 39 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.43985697 |
| 40 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.43400505 |
| 41 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.43363058 |
| 42 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.43274387 |
| 43 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.43046913 |
| 44 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.41347387 |
| 45 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.41347387 |
| 46 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.40845342 |
| 47 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.40211787 |
| 48 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.39918085 |
| 49 | AR_25329375_ChIP-Seq_VCAP_Human | 1.39467429 |
| 50 | VDR_22108803_ChIP-Seq_LS180_Human | 1.39371473 |
| 51 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.35163186 |
| 52 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 1.32695743 |
| 53 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.30719360 |
| 54 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.30563458 |
| 55 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.30341036 |
| 56 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.30205499 |
| 57 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.29178075 |
| 58 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.28348060 |
| 59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.26835349 |
| 60 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26803790 |
| 61 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.26599174 |
| 62 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.24471443 |
| 63 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.24357264 |
| 64 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.23326697 |
| 65 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.23042443 |
| 66 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.22454841 |
| 67 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20837237 |
| 68 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.20521607 |
| 69 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.19234053 |
| 70 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.17873799 |
| 71 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.16477790 |
| 72 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.15924691 |
| 73 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.15908696 |
| 74 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.15106478 |
| 75 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.15087107 |
| 76 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.12960597 |
| 77 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.11710355 |
| 78 | EWS_26573619_Chip-Seq_HEK293_Human | 1.11427746 |
| 79 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.11421003 |
| 80 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.11400648 |
| 81 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.11279738 |
| 82 | AR_19668381_ChIP-Seq_PC3_Human | 1.10806510 |
| 83 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.09842534 |
| 84 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.09639623 |
| 85 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.09179575 |
| 86 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.08002500 |
| 87 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.07968563 |
| 88 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.07612354 |
| 89 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.07021048 |
| 90 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.06100950 |
| 91 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.05281961 |
| 92 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.04798171 |
| 93 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.04539571 |
| 94 | CJUN_26792858_Chip-Seq_BT549_Human | 1.03995422 |
| 95 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.02378791 |
| 96 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.02078029 |
| 97 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.01509812 |
| 98 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.00940538 |
| 99 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.00604043 |
| 100 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99024259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 8.09250991 |
| 2 | MP0003136_yellow_coat_color | 6.91347942 |
| 3 | MP0005171_absent_coat_pigmentation | 6.36027430 |
| 4 | MP0002653_abnormal_ependyma_morphology | 5.33575857 |
| 5 | MP0000569_abnormal_digit_pigmentation | 4.77693982 |
| 6 | MP0003045_fibrosis | 4.75255267 |
| 7 | MP0003890_abnormal_embryonic-extraembry | 3.62424404 |
| 8 | MP0003646_muscle_fatigue | 3.36738785 |
| 9 | MP0003879_abnormal_hair_cell | 3.13760016 |
| 10 | MP0005670_abnormal_white_adipose | 3.05592084 |
| 11 | MP0004381_abnormal_hair_follicle | 2.92212367 |
| 12 | MP0002168_other_aberrant_phenotype | 2.16600202 |
| 13 | MP0002735_abnormal_chemical_nociception | 2.12499669 |
| 14 | MP0005075_abnormal_melanosome_morpholog | 2.04080775 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 1.99158586 |
| 16 | MP0005085_abnormal_gallbladder_physiolo | 1.85934380 |
| 17 | MP0003137_abnormal_impulse_conducting | 1.64158432 |
| 18 | MP0005174_abnormal_tail_pigmentation | 1.60964278 |
| 19 | MP0003195_calcinosis | 1.60797068 |
| 20 | MP0001486_abnormal_startle_reflex | 1.54904982 |
| 21 | MP0002095_abnormal_skin_pigmentation | 1.50724269 |
| 22 | MP0001501_abnormal_sleep_pattern | 1.49826832 |
| 23 | MP0009046_muscle_twitch | 1.47354403 |
| 24 | MP0000749_muscle_degeneration | 1.45489530 |
| 25 | MP0001984_abnormal_olfaction | 1.40988998 |
| 26 | MP0002938_white_spotting | 1.34089930 |
| 27 | MP0003705_abnormal_hypodermis_morpholog | 1.28487414 |
| 28 | MP0005395_other_phenotype | 1.25874931 |
| 29 | MP0002075_abnormal_coat/hair_pigmentati | 1.25853755 |
| 30 | MP0004859_abnormal_synaptic_plasticity | 1.23866230 |
| 31 | MP0004233_abnormal_muscle_weight | 1.20694878 |
| 32 | MP0001529_abnormal_vocalization | 1.19816443 |
| 33 | MP0002160_abnormal_reproductive_system | 1.17163446 |
| 34 | MP0008872_abnormal_physiological_respon | 1.16635514 |
| 35 | MP0000015_abnormal_ear_pigmentation | 1.12134958 |
| 36 | MP0002272_abnormal_nervous_system | 1.09172865 |
| 37 | MP0002733_abnormal_thermal_nociception | 1.04538947 |
| 38 | MP0003635_abnormal_synaptic_transmissio | 1.04159987 |
| 39 | MP0004147_increased_porphyrin_level | 1.03280227 |
| 40 | MP0001970_abnormal_pain_threshold | 1.02382078 |
| 41 | MP0010352_gastrointestinal_tract_polyps | 1.00985770 |
| 42 | MP0003183_abnormal_peptide_metabolism | 0.96779632 |
| 43 | MP0009745_abnormal_behavioral_response | 0.92626382 |
| 44 | MP0001440_abnormal_grooming_behavior | 0.92521732 |
| 45 | MP0002572_abnormal_emotion/affect_behav | 0.88226908 |
| 46 | MP0004043_abnormal_pH_regulation | 0.86510176 |
| 47 | MP0005551_abnormal_eye_electrophysiolog | 0.86194260 |
| 48 | MP0002971_abnormal_brown_adipose | 0.80206557 |
| 49 | MP0004270_analgesia | 0.80183773 |
| 50 | MP0005365_abnormal_bile_salt | 0.79816923 |
| 51 | MP0001186_pigmentation_phenotype | 0.78517004 |
| 52 | MP0002064_seizures | 0.78147440 |
| 53 | MP0008569_lethality_at_weaning | 0.77614160 |
| 54 | MP0005386_behavior/neurological_phenoty | 0.76264353 |
| 55 | MP0004924_abnormal_behavior | 0.76264353 |
| 56 | MP0000778_abnormal_nervous_system | 0.70530485 |
| 57 | MP0002269_muscular_atrophy | 0.68760089 |
| 58 | MP0003632_abnormal_nervous_system | 0.67744744 |
| 59 | MP0001968_abnormal_touch/_nociception | 0.67419868 |
| 60 | MP0002067_abnormal_sensory_capabilities | 0.66053833 |
| 61 | MP0002063_abnormal_learning/memory/cond | 0.65962885 |
| 62 | MP0000534_abnormal_ureter_morphology | 0.65905688 |
| 63 | MP0002229_neurodegeneration | 0.65464001 |
| 64 | MP0003329_amyloid_beta_deposits | 0.65060480 |
| 65 | MP0008770_decreased_survivor_rate | 0.63738184 |
| 66 | MP0005330_cardiomyopathy | 0.57074235 |
| 67 | MP0005410_abnormal_fertilization | 0.55998215 |
| 68 | MP0003787_abnormal_imprinting | 0.54730495 |
| 69 | MP0000427_abnormal_hair_cycle | 0.53807689 |
| 70 | MP0002277_abnormal_respiratory_mucosa | 0.53755377 |
| 71 | MP0008877_abnormal_DNA_methylation | 0.52979000 |
| 72 | MP0002734_abnormal_mechanical_nocicepti | 0.52272466 |
| 73 | MP0005389_reproductive_system_phenotype | 0.52061151 |
| 74 | MP0002876_abnormal_thyroid_physiology | 0.51986360 |
| 75 | MP0001324_abnormal_eye_pigmentation | 0.51678037 |
| 76 | MP0003252_abnormal_bile_duct | 0.49281444 |
| 77 | MP0002102_abnormal_ear_morphology | 0.47901872 |
| 78 | MP0003631_nervous_system_phenotype | 0.47818415 |
| 79 | MP0002882_abnormal_neuron_morphology | 0.47764884 |
| 80 | MP0002557_abnormal_social/conspecific_i | 0.46722776 |
| 81 | MP0000371_diluted_coat_color | 0.45429846 |
| 82 | MP0006072_abnormal_retinal_apoptosis | 0.44951512 |
| 83 | MP0002254_reproductive_system_inflammat | 0.44132396 |
| 84 | MP0004142_abnormal_muscle_tone | 0.43329307 |
| 85 | MP0000026_abnormal_inner_ear | 0.43282980 |
| 86 | MP0003698_abnormal_male_reproductive | 0.43148202 |
| 87 | MP0002736_abnormal_nociception_after | 0.42932147 |
| 88 | MP0008789_abnormal_olfactory_epithelium | 0.42861744 |
| 89 | MP0009115_abnormal_fat_cell | 0.39981262 |
| 90 | MP0002752_abnormal_somatic_nervous | 0.39892571 |
| 91 | MP0004484_altered_response_of | 0.39866187 |
| 92 | MP0005620_abnormal_muscle_contractility | 0.39466519 |
| 93 | MP0003959_abnormal_lean_body | 0.39426657 |
| 94 | MP0002928_abnormal_bile_duct | 0.39215591 |
| 95 | MP0001963_abnormal_hearing_physiology | 0.39128905 |
| 96 | MP0002751_abnormal_autonomic_nervous | 0.38306673 |
| 97 | MP0003937_abnormal_limbs/digits/tail_de | 0.36796735 |
| 98 | MP0005394_taste/olfaction_phenotype | 0.36418394 |
| 99 | MP0005499_abnormal_olfactory_system | 0.36418394 |
| 100 | MP0005195_abnormal_posterior_eye | 0.35869058 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.37409320 |
| 2 | Amelogenesis imperfecta (HP:0000705) | 7.46059939 |
| 3 | Parakeratosis (HP:0001036) | 6.15831997 |
| 4 | Acanthocytosis (HP:0001927) | 5.75795373 |
| 5 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 5.50296483 |
| 6 | Pancreatic cysts (HP:0001737) | 4.68012411 |
| 7 | Dialeptic seizures (HP:0011146) | 4.67127534 |
| 8 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 4.27856152 |
| 9 | Focal seizures (HP:0007359) | 3.84731767 |
| 10 | Colon cancer (HP:0003003) | 3.72291668 |
| 11 | Hematochezia (HP:0002573) | 3.57782652 |
| 12 | Aplastic anemia (HP:0001915) | 3.57131865 |
| 13 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.50331627 |
| 14 | Proximal amyotrophy (HP:0007126) | 3.47090946 |
| 15 | Spontaneous hematomas (HP:0007420) | 3.32916771 |
| 16 | Abnormality of the renal medulla (HP:0100957) | 3.25017908 |
| 17 | Nephronophthisis (HP:0000090) | 3.23577174 |
| 18 | Rectal prolapse (HP:0002035) | 3.23112728 |
| 19 | Erythroderma (HP:0001019) | 3.18650166 |
| 20 | Difficulty walking (HP:0002355) | 3.10367000 |
| 21 | Congenital stationary night blindness (HP:0007642) | 3.01440711 |
| 22 | Abnormality of the renal cortex (HP:0011035) | 3.00142332 |
| 23 | Chromsome breakage (HP:0040012) | 2.98521888 |
| 24 | Pancreatic fibrosis (HP:0100732) | 2.94537698 |
| 25 | Esophageal varix (HP:0002040) | 2.91473417 |
| 26 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.91297658 |
| 27 | Potter facies (HP:0002009) | 2.88470261 |
| 28 | Facial shape deformation (HP:0011334) | 2.88470261 |
| 29 | Overlapping toe (HP:0001845) | 2.87954983 |
| 30 | Febrile seizures (HP:0002373) | 2.83463382 |
| 31 | Poikilocytosis (HP:0004447) | 2.68249609 |
| 32 | Ulnar claw (HP:0001178) | 2.66929649 |
| 33 | Cystic liver disease (HP:0006706) | 2.63543566 |
| 34 | Global brain atrophy (HP:0002283) | 2.60773185 |
| 35 | Synostosis of carpal bones (HP:0005048) | 2.58975841 |
| 36 | Pendular nystagmus (HP:0012043) | 2.58324802 |
| 37 | Vertebral arch anomaly (HP:0008438) | 2.50450423 |
| 38 | Abnormality of the vocal cords (HP:0008777) | 2.49645756 |
| 39 | Duplicated collecting system (HP:0000081) | 2.49042277 |
| 40 | Prolonged partial thromboplastin time (HP:0003645) | 2.48869242 |
| 41 | Bile duct proliferation (HP:0001408) | 2.46465674 |
| 42 | Abnormal biliary tract physiology (HP:0012439) | 2.46465674 |
| 43 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.44483061 |
| 44 | Abnormality of the renal collecting system (HP:0004742) | 2.42573063 |
| 45 | Autoimmune hemolytic anemia (HP:0001890) | 2.41554635 |
| 46 | Scapular winging (HP:0003691) | 2.41465980 |
| 47 | Joint hemorrhage (HP:0005261) | 2.40543914 |
| 48 | True hermaphroditism (HP:0010459) | 2.31700211 |
| 49 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.31273065 |
| 50 | Inability to walk (HP:0002540) | 2.29385345 |
| 51 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.26379321 |
| 52 | Broad-based gait (HP:0002136) | 2.22920555 |
| 53 | Progressive inability to walk (HP:0002505) | 2.20786857 |
| 54 | Tubulointerstitial fibrosis (HP:0005576) | 2.16491579 |
| 55 | Cerebellar dysplasia (HP:0007033) | 2.16434494 |
| 56 | Molar tooth sign on MRI (HP:0002419) | 2.15890824 |
| 57 | Abnormality of midbrain morphology (HP:0002418) | 2.15890824 |
| 58 | Abnormality of the intrinsic pathway (HP:0010989) | 2.15755608 |
| 59 | Enlarged kidneys (HP:0000105) | 2.11712137 |
| 60 | Abnormality of macular pigmentation (HP:0008002) | 2.11442839 |
| 61 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.10948677 |
| 62 | Conical tooth (HP:0000698) | 2.10179482 |
| 63 | Atonic seizures (HP:0010819) | 2.10149988 |
| 64 | Neoplasm of the small intestine (HP:0100833) | 2.07688277 |
| 65 | Conjunctival telangiectasia (HP:0000524) | 2.03190143 |
| 66 | Absence seizures (HP:0002121) | 2.01551614 |
| 67 | Volvulus (HP:0002580) | 1.98761605 |
| 68 | Tarsal synostosis (HP:0008368) | 1.97377129 |
| 69 | Broad ribs (HP:0000885) | 1.97080638 |
| 70 | Tubular atrophy (HP:0000092) | 1.94313313 |
| 71 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.92568165 |
| 72 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.89911863 |
| 73 | Oligodontia (HP:0000677) | 1.89350096 |
| 74 | Reticulocytopenia (HP:0001896) | 1.87326779 |
| 75 | Asplenia (HP:0001746) | 1.87161389 |
| 76 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.86569756 |
| 77 | Synostosis involving bones of the feet (HP:0009140) | 1.86569756 |
| 78 | Meningioma (HP:0002858) | 1.84846119 |
| 79 | Portal hypertension (HP:0001409) | 1.84427288 |
| 80 | Albinism (HP:0001022) | 1.84067180 |
| 81 | Hypokalemia (HP:0002900) | 1.83565292 |
| 82 | Drooling (HP:0002307) | 1.83039753 |
| 83 | Absent speech (HP:0001344) | 1.81007566 |
| 84 | Radial bowing (HP:0002986) | 1.79944203 |
| 85 | Vacuolated lymphocytes (HP:0001922) | 1.79734073 |
| 86 | Abnormal albumin level (HP:0012116) | 1.78857583 |
| 87 | Hypoalbuminemia (HP:0003073) | 1.78857583 |
| 88 | Retinitis pigmentosa (HP:0000510) | 1.77870123 |
| 89 | Ulnar bowing (HP:0003031) | 1.77349419 |
| 90 | Increased cerebral lipofuscin (HP:0011813) | 1.74719495 |
| 91 | Impaired smooth pursuit (HP:0007772) | 1.74652343 |
| 92 | Decreased circulating renin level (HP:0003351) | 1.73951511 |
| 93 | Severe visual impairment (HP:0001141) | 1.73759415 |
| 94 | Clubbing of toes (HP:0100760) | 1.72593853 |
| 95 | Type II lissencephaly (HP:0007260) | 1.71956698 |
| 96 | Congenital hepatic fibrosis (HP:0002612) | 1.71776484 |
| 97 | Excessive salivation (HP:0003781) | 1.67344966 |
| 98 | Clumsiness (HP:0002312) | 1.67266651 |
| 99 | Hyperalaninemia (HP:0003348) | 1.66717553 |
| 100 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.66717553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LATS1 | 9.73612030 |
| 2 | STK38L | 6.57104663 |
| 3 | LATS2 | 5.72024116 |
| 4 | PINK1 | 3.40412777 |
| 5 | FRK | 2.98740821 |
| 6 | PRKD3 | 2.79261029 |
| 7 | NLK | 2.70821444 |
| 8 | MAP3K4 | 2.61635818 |
| 9 | STK38 | 2.48971757 |
| 10 | ZAK | 2.46725886 |
| 11 | MAP3K6 | 2.35397927 |
| 12 | MAP2K7 | 1.95207938 |
| 13 | ACVR1B | 1.86473074 |
| 14 | MAP2K2 | 1.85476887 |
| 15 | STK3 | 1.74945275 |
| 16 | GRK1 | 1.52609467 |
| 17 | MAP3K2 | 1.35796059 |
| 18 | ADRBK2 | 1.34829086 |
| 19 | MELK | 1.20428011 |
| 20 | BMPR1B | 1.16854973 |
| 21 | NEK2 | 1.12320529 |
| 22 | PIK3CG | 1.11775185 |
| 23 | CASK | 1.08510461 |
| 24 | MAP2K4 | 1.05011114 |
| 25 | KSR2 | 0.98923191 |
| 26 | CSNK1A1L | 0.93322584 |
| 27 | CCNB1 | 0.90265503 |
| 28 | EIF2AK3 | 0.90158627 |
| 29 | WNK4 | 0.89335031 |
| 30 | MARK1 | 0.79455753 |
| 31 | DAPK2 | 0.78352985 |
| 32 | ADRBK1 | 0.77320218 |
| 33 | PRKAA2 | 0.68604052 |
| 34 | GRK7 | 0.67183473 |
| 35 | IRAK3 | 0.60404969 |
| 36 | RET | 0.54345134 |
| 37 | PDPK1 | 0.54307745 |
| 38 | MAP3K5 | 0.53857835 |
| 39 | SIK2 | 0.49919676 |
| 40 | NTRK3 | 0.44473947 |
| 41 | CSNK1G1 | 0.44462991 |
| 42 | STK39 | 0.44005459 |
| 43 | TGFBR1 | 0.41975946 |
| 44 | FER | 0.35976448 |
| 45 | DYRK1A | 0.35706715 |
| 46 | STK11 | 0.35122691 |
| 47 | MAPK7 | 0.34054348 |
| 48 | PRKD1 | 0.33901038 |
| 49 | CDK3 | 0.33721713 |
| 50 | GRK5 | 0.33512443 |
| 51 | MAP2K6 | 0.33362440 |
| 52 | PHKG1 | 0.31640038 |
| 53 | PHKG2 | 0.31640038 |
| 54 | TGFBR2 | 0.31433442 |
| 55 | SCYL2 | 0.31340877 |
| 56 | MAPK13 | 0.30239678 |
| 57 | MAP2K1 | 0.30230881 |
| 58 | WNK3 | 0.30220985 |
| 59 | PBK | 0.30123381 |
| 60 | DYRK2 | 0.30061799 |
| 61 | FGFR3 | 0.29324667 |
| 62 | MAP3K1 | 0.27974683 |
| 63 | OXSR1 | 0.26393197 |
| 64 | TEC | 0.26237925 |
| 65 | TAOK1 | 0.26188655 |
| 66 | CAMK2B | 0.25214771 |
| 67 | PRKCG | 0.23655867 |
| 68 | CDK5 | 0.22322605 |
| 69 | PRKCE | 0.21871067 |
| 70 | PIM1 | 0.20401873 |
| 71 | PRKG2 | 0.17691183 |
| 72 | TAF1 | 0.16337698 |
| 73 | TAOK3 | 0.15931322 |
| 74 | CSNK1A1 | 0.15142204 |
| 75 | PRKACA | 0.13696938 |
| 76 | CAMK2A | 0.13695328 |
| 77 | NUAK1 | 0.13242320 |
| 78 | MAPK3 | 0.13042110 |
| 79 | MOS | 0.12994771 |
| 80 | CSNK1D | 0.12960839 |
| 81 | PRKACB | 0.12775272 |
| 82 | MAPK8 | 0.11657203 |
| 83 | GSK3B | 0.11021708 |
| 84 | PIK3CA | 0.10858729 |
| 85 | ABL1 | 0.10355188 |
| 86 | PLK1 | 0.10311855 |
| 87 | TNK2 | 0.09770977 |
| 88 | TAOK2 | 0.09053426 |
| 89 | TRIM28 | 0.09011580 |
| 90 | MINK1 | 0.08722133 |
| 91 | PLK4 | 0.07816869 |
| 92 | CDK19 | 0.07731290 |
| 93 | MAP4K2 | 0.06109846 |
| 94 | TXK | 0.04225890 |
| 95 | SGK1 | 0.03976831 |
| 96 | AKT2 | 0.03492272 |
| 97 | MAPK1 | 0.03239350 |
| 98 | PRKCB | 0.02221522 |
| 99 | CSNK1G2 | 0.02097810 |
| 100 | MAPK4 | 0.01904267 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 6.40382394 |
| 2 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 4.93102010 |
| 3 | Phototransduction_Homo sapiens_hsa04744 | 4.65663705 |
| 4 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 3.65132643 |
| 5 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 3.44702188 |
| 6 | Nicotine addiction_Homo sapiens_hsa05033 | 3.31088545 |
| 7 | Taste transduction_Homo sapiens_hsa04742 | 3.11180513 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.90136312 |
| 9 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 2.28748848 |
| 10 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.23084300 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 2.12132830 |
| 12 | GABAergic synapse_Homo sapiens_hsa04727 | 1.92344008 |
| 13 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.83089354 |
| 14 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.72297047 |
| 15 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.58380803 |
| 16 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.24957411 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.24190633 |
| 18 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.21156971 |
| 19 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.20719852 |
| 20 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.20537520 |
| 21 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.17671824 |
| 22 | Circadian entrainment_Homo sapiens_hsa04713 | 1.15078906 |
| 23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.11668584 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.10988886 |
| 25 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.07108761 |
| 26 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.05642897 |
| 27 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.02317501 |
| 28 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.99133253 |
| 29 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.98969418 |
| 30 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.97808576 |
| 31 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.97577275 |
| 32 | Salivary secretion_Homo sapiens_hsa04970 | 0.96856434 |
| 33 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.93939515 |
| 34 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.86439739 |
| 35 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.85206514 |
| 36 | Olfactory transduction_Homo sapiens_hsa04740 | 0.83772684 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 0.83731132 |
| 38 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.83355852 |
| 39 | Long-term depression_Homo sapiens_hsa04730 | 0.79063227 |
| 40 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.78795651 |
| 41 | Basal transcription factors_Homo sapiens_hsa03022 | 0.76201915 |
| 42 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.74330774 |
| 43 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.72878594 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.70499622 |
| 45 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.66475235 |
| 46 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.65996428 |
| 47 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.65859427 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 0.65528209 |
| 49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.65491676 |
| 50 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.61478075 |
| 51 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.60794485 |
| 52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60673076 |
| 53 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.60497407 |
| 54 | Viral myocarditis_Homo sapiens_hsa05416 | 0.60483423 |
| 55 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.58503071 |
| 56 | Gap junction_Homo sapiens_hsa04540 | 0.58411717 |
| 57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53866513 |
| 58 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.51907595 |
| 59 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.50495141 |
| 60 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.48339120 |
| 61 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.48172594 |
| 62 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.47821672 |
| 63 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.46917269 |
| 64 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.44881592 |
| 65 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.44308122 |
| 66 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.44145144 |
| 67 | Platelet activation_Homo sapiens_hsa04611 | 0.42483076 |
| 68 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.42315938 |
| 69 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.40592760 |
| 70 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.40330516 |
| 71 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.37714065 |
| 72 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.37337331 |
| 73 | Colorectal cancer_Homo sapiens_hsa05210 | 0.36002008 |
| 74 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.35787745 |
| 75 | Insulin secretion_Homo sapiens_hsa04911 | 0.34248378 |
| 76 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.33453632 |
| 77 | Lysine degradation_Homo sapiens_hsa00310 | 0.33120519 |
| 78 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.32930506 |
| 79 | Tuberculosis_Homo sapiens_hsa05152 | 0.32031650 |
| 80 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.31595019 |
| 81 | Retinol metabolism_Homo sapiens_hsa00830 | 0.31129343 |
| 82 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.30857327 |
| 83 | Renin secretion_Homo sapiens_hsa04924 | 0.30561192 |
| 84 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.28713036 |
| 85 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.28172314 |
| 86 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.26563717 |
| 87 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.26334716 |
| 88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.26072403 |
| 89 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.25513623 |
| 90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.24874041 |
| 91 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.24364745 |
| 92 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.24098793 |
| 93 | Long-term potentiation_Homo sapiens_hsa04720 | 0.23722133 |
| 94 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.23403227 |
| 95 | Adherens junction_Homo sapiens_hsa04520 | 0.20410460 |
| 96 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.19793440 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18570551 |
| 98 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.17157707 |
| 99 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.16080439 |
| 100 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.15879804 |

